Drug-Eluting Balloons

This channel includes news and new technology innovations for drug coated balloons, also referred to as drug-eluting balloons. These are used to treat peripheral and coronary artery lesions and restenosis.

Spectranetics Announces FDA Approval of Stellarex Drug-Coated Balloon
Technology | Drug-Eluting Balloons | July 26, 2017

July 26, 2017 — The Spectranetics Corp. announced receipt of U.S. Food and Drug Administration (FDA) pre-market...

Philips acquires purchases Spectranetics
Feature | Cardiovascular Business | June 28, 2017

June 28, 2017 — Philips Healthcare...

News | June 12, 2017

June 12, 2017 – Med Alliance announced completion on schedule of patient enrollment in the first-in-man (FIM) study...

Twelve-Month Data Positive for Ranger Paclitaxel-Coated Balloon Catheter
News | Drug-Eluting Balloons | April 26, 2017

April 26, 2017 — Boston Scientific announced results from the RANGER SFA trial for the Ranger Paclitaxel-Coated PTA...

Medtronic, IN.PACT Admiral DCB, drug-coated balloon, below-the-knee, European BTK IN.PACT clinical study, peripheral artery disease, PAD, launch
News | Peripheral Artery Disease (PAD) | March 09, 2017

March 9, 2017 — Medtronic plc announced the launch of the IN.PACT BTK study to evaluate the effectiveness of a...

Medtronic, IDE approval, IN.PACT Admiral drug-coated balloon, DCB, end-stage renal disease
News | Drug-Eluting Balloons | February 08, 2017

February 8, 2017 — Medtronic plc announced receipt of an investigational device exemption (IDE) from the U.S. Food...

Spectranetics, Stellarex 0.014-inch DCB, CE Mark
News | Drug-Eluting Balloons | December 06, 2016

December 6, 2016 — The Spectranetics Corp. announced in late November that its Stellarex 0.014-inch...

Bard, Lutonix 014 DCB, drug-coated balloon, six-month endpoint, FDA IDE trial
Technology | Drug-Eluting Balloons | September 26, 2016

September 26, 2016 — C. R. Bard Inc. announced the U.S. Food and Drug Administration (FDA) approved an...

Medtronic, In.Pact Admiral drug-coated balloon, trial data, VIVA
News | Drug-Eluting Balloons | September 22, 2016

September 22, 2016 — New data presented at the Vascular Interventional Advances (VIVA) conference demonstrated the...

Medtronic, IN.PACT Admiral drug-coated balloon, DCB, FDA approval, in-stent restenosis, ISR
Technology | Drug-Eluting Balloons | September 19, 2016

September 19, 2016 — Medtronic plc announced that the U.S. Food and Drug Administration (FDA) approved the IN.PACT...

VIVA 2016, late breaking trials, cath lab
Feature | Cath Lab | September 14, 2016

Vascular Interventional Advances (VIVA) 2016 released its list late-breaking research presentations in vascular...

Medtronic, In.Pact Admiral drug coated balloon, DCB, FDA approval, 150 mm length
Technology | Drug-Eluting Balloons | July 18, 2016

July 18, 2016 — Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for the IN.PACT Admiral...

News | Drug-Eluting Balloons | June 03, 2016

June 3, 2016 — Cardionovum GmbH recently announced the completion of enrollment of the RAPID trial. Results will be...

Intact Vascular, Tack Endovascular System

The Intact Vascular Tack Endovascular System is designed to spot stent dissections with a short, self-expanding 6 mm long stent that can expand to vessel diameters between 2.5-6 mm, so exact sizing is not needed.

Feature | Peripheral Artery Disease (PAD) | February 22, 2016 | Dave Fornell

It is estimated that more than 10 million people in the United States are affected by...

Medtronic, CE Mark, IN.PACT Admiral DEB, arteriovenous AV access, hemodialysis, end-stage renal disease patients
News | Drug-Eluting Balloons | January 18, 2016

January 18, 2016 — Medtronic plc announced that the IN.PACT Admiral ...

Overlay Init